Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Ductal Adenocarcinoma (mPDAC)”

19 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 19 results

Large-scale testing (Phase 3)Study completedNCT04935359
What this trial is testing

Study of Efficacy and Safety of NIS793 in Combination With Standard of Care (SOC) Chemotherapy in First-line Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) - daNIS-2

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma
Novartis Pharmaceuticals 511
Testing effectiveness (Phase 2)Looking for participantsNCT07284277
What this trial is testing

TTFields and Chemotherapy in Metastatic Pancreatic Adenocarcinoma (mPDAC)

Who this might be right for
Pancreatic Adenocarcinoma MetastaticPancreatic Ductal Adenocarcinoma
Clinica Universidad de Navarra, Universidad de Navarra 30
Testing effectiveness (Phase 2)Study completedNCT06390059
What this trial is testing

EF-39 PANOVA-4: Study of Tumor Treating Fields Concomitant With Atezolizumab, Gemcitabine and Nab-Paclitaxel as First-LineTreatment for Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma
NovoCure Ltd. 84
Testing effectiveness (Phase 2)Ended earlyNCT04390763
What this trial is testing

Study of Efficacy and Safety of NIS793 (With and Without Spartalizumab) in Combination With SOC Chemotherapy in First-line Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma
Novartis Pharmaceuticals 164
Testing effectiveness (Phase 2)Ended earlyNCT05114213
What this trial is testing

MR-Guided Adaptive SBRT of Primary Tumor for Pain Control in Metastatic PDAC

Who this might be right for
Pancreatic Cancer
Ludwig-Maximilians - University of Munich 9
Testing effectiveness (Phase 2)Study completedNCT06119217
What this trial is testing

Phase 2 Study of TTX-030 and Chemotherapy With or Without Budigalimab for 1L mPDAC Patients

Who this might be right for
Pancreatic Cancer
Trishula Therapeutics, Inc. 194
Large-scale testing (Phase 3)Looking for participantsNCT07165951
What this trial is testing

Clinical Trial Comparing TQB2868 Injection Combined With Anlotinib Hydrochloride Capsules With Placebo Combined With Chemotherapy as First-line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. 566
Testing effectiveness (Phase 2)WithdrawnNCT06592664
What this trial is testing

Certepetide Phase 1b/2a Continuous Infusion Trial in mPDAC

Who this might be right for
Pancreas CancerPancreatic CarcinomaPancreas Adenocarcinoma+5 more
Lisata Therapeutics, Inc.
Not applicableNot Yet RecruitingNCT06655142
What this trial is testing

OSCAR II STUDY - The ONCObind CTC Removal Study

Who this might be right for
Pancreatic Ductal Adenocarcinoma (mPDAC)Metastatic Colorectal Carcinoma (mCRC)
ExThera Medical Corporation 120
Not applicableLooking for participantsNCT07144917
What this trial is testing

Immunoparalysis After Pancreaticoduodenectomy

Who this might be right for
Pancreatic Ductal Adenocarcinoma (mPDAC)Pancreatic Head TumourPancreatic Fistula
Hospices Civils de Lyon 100
Early research (Phase 1)Study completedNCT02501902
What this trial is testing

Dose-Escalation Study Of Palbociclib + Nab-Paclitaxel In mPDAC

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma
Pfizer 76
Not applicableNo Longer AvailableNCT07399015
What this trial is testing

Expanded Access to Mifomelatide for Cachexia in Adults With Advanced PDAC

Who this might be right for
Pancreatic Ductal Adenocarcinoma (mPDAC)Unresectable Pancreatic Ductal AdenocarcinomaMetastatic PDAC
Endevica Bio
Large-scale testing (Phase 3)Ended earlyNCT04329949
What this trial is testing

Study of Relacorilant in Combination With Nab-Paclitaxel in Patients With Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma
Corcept Therapeutics 43
Not applicableUnknownNCT06155136
What this trial is testing

RWE on Patients With mPDAC Long-term Survival After Treatment With Liposomal Irinotecan

Who this might be right for
Pancreatic Cancer Metastatic
Servier Affaires Médicales 163
Early research (Phase 1)Ended earlyNCT06528093
What this trial is testing

Find a Suitable Dose of BI 765883 and to Test Whether it Helps People With Advanced Pancreatic Cancer When Taken Alone or Together With Chemotherapy

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Boehringer Ingelheim 8
Testing effectiveness (Phase 2)Looking for participantsNCT06790602
What this trial is testing

Cemiplimab Plus Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma (mPDAC)
University of California, San Diego 43
Not applicableNot Yet RecruitingNCT07516392
What this trial is testing

Study of a Polygenic Risk Score to Predict the Risk of Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma (mPDAC)
Catholic University of the Sacred Heart 1,140
Not applicableNot Yet RecruitingNCT07444840
What this trial is testing

How Does Pre-operative Biliary Drainage in Pancreatic Adenocarcinoma Affect Surgical Outcomes in Pancreatic Cancer Surgery

Who this might be right for
Pancreatic Ductal Adenocarcinoma (mPDAC)Pancreatic Ductal Adenocarcinoma (PDAC)
East Lancashire Hospitals NHS Trust 90
Early research (Phase 1)Looking for participantsNCT07481357
What this trial is testing

A First-In-Human Phase I/IIa Study to Evaluate DA 3501 in Patients With Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma and Pancreatic Ductal Adenocarcinoma

Who this might be right for
Gastric (Stomach) CancerGastroEsophageal CancerPancreatic Ductal Adenocarcinoma (mPDAC)
Dong-A ST Co., Ltd. 51